Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01561378 · ClinicalTrials.gov registry record · Phase 2
Cardiac Surgery Neuroprotection Study in Elders
A Phase 2 study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 22
- Enrollment target
NCT01561378 is a Phase 2 study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 22 participants.
The verdict
NCT01561378, a Phase 2 study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 22 participants
- Enrollment target
Study Summary
The goal of this study is to determine the potential ability of intranasal insulin to prevent post-operative cognitive decline and post-operative delirium in an elderly cardiac surgery population.
Interventions
- DRUG Normal saline
- DRUG Aspart insulin
- DEVICE Intranasal mucosal atomizer device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2012-08 |
| Est. Completion | 2014-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01561378
The ClinicalTrials.gov registry entry for NCT01561378 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Normal saline is the first listed.
NCT01561378 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01561378 about?
NCT01561378 is a clinical study titled "Cardiac Surgery Neuroprotection Study in Elders". The goal of this study is to determine the potential ability of intranasal insulin to prevent post-operative cognitive decline and post-operative delirium in an elderly cardiac surgery population.
What is the current status of trial NCT01561378?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 22 participants. The study started on 2012-08. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01561378?
The interventions under investigation include: Normal saline (DRUG), Aspart insulin (DRUG), Intranasal mucosal atomizer device (DEVICE).
Who is sponsoring clinical trial NCT01561378?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.